图书简介
Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy, Second Edition, provides a comprehensive overview of the molecular methodologies in the neuro-oncology field. There have been profound changes in the landscape of approaches to brain tumor therapy since the first edition-mainly in the areas of molecular biology and molecular therapeutics, as well as in the maturation of immunotherapy approaches (e.g., vaccines). This updated edition has a new, primary focus on multidisciplinary molecular methods, and is broadened to include the latest cutting-edge molecular biology, therapeutics, immunobiology and immunotherapy approaches. As the first comprehensive book to address the molecular research into these concepts, users will find it to be an invaluable resource on the topics discussed.
SECTION I. PHARMACOLOGICAL AND CLINICAL APPLICATIONS 1. Overview of Brain Tumor Epidemiology and Histopathology 2. Clinical Pharmacology of Brain Tumor Chemotherapy 3. Antiepileptic drugs and chemotherapy: Potential interactions and impact on treatment of patients with cancer 4. Brain Tumor Models for Cancer Therapy 5. Genomics and proteomics in neuro-oncology 6. Chemotherapy Resistance 7. Clinical Trial Design and Implementation in Neuro-Oncology 8. Biology of the Blood-Brain and Blood-Brain Tumor Barriers SECTION II. INNOVATIVE CHEMOTHERAPY DELIVERY 9. Intra-arterial Chemotherapy 10. Blood-Brain Barrier Disruption Chemotherapy 11. Interstitial Chemotherapy and Polymer-Drug Delivery 12. Intratumoral Chemotherapy and Convection-Enhanced Delivery 13. Marrow-Ablative Chemotherapy with Autologous Hematopoietic Progenitor Cell Rescue in Brain Tumors 14. CSF Dissemination of Primary Brain Tumors 15. Gene/Viral Treatment Approaches for Malignant Brain Cancer 16. Nanoparticles as Therapeutic Agents for Brain Tumors SECTION III. MOLECULAR BIOLOGY AND MOLECULAR THERAPEUTICS 17. Overview of Molecular Genetics of Brain Tumors 18. Cell Cycle Regulation 19. Targeting cell cycle proteins in brain cancer 20. Apoptosis Pathways and Chemotherapy in Brain Tumors 21. Growth Factor Signaling Pathways and Targeted Therapy 22. Targeting the RAS-RAF-MEK-ERK Signaling Pathway in Gliomas 23. PI3-kinase, Akt, mTOR and Treatment 24. Scatter Factor/HGF and C-MET in Glioblastoma 25. Targeting the sonic hedgehog pathway in brain cancers: Advances, limitations, and future directions 26. Angiogenesis and angiogenesis inhibitors in brain tumors 27. Bevacizumab and Brain Tumors 28. Histone Deacetylase Inhibitors as Therapeutic Agents SECTION IV. CHEMOTHERAPY FOR SPECIFIC TUMORS - ADULTS 29. Historial and conventional chemotherapy approaches for high grade astrocytomas 30. The use of temozolomide for chemo-radiation and adjuvant therapy of high-grade gliomas 31. Molecular Treatment of High-Grade Glioma 32. Chemotherapy of Low-Grade Astrocytomas 33. Chemotherapy of Oligodendrogliomas 34. Chemotherapy of Primary Central Nervous System Lymphoma 35. Chemotherapy for Medulloblastoma in Adults 36. Chemotherapy of Adult Ependymoma 37. Chemotherapy for Glioneuronal Tumors 38. Medical therapy of Schwannomas 39. Chemotherapy of Pineal Parenchymal Tumors 40. Chemotherapy of Meningiomas 41. Chemotherapy of Brain Metastases SECTION V. CHEMOTHERAPY FOR SPECIFIC TUMORS - PEDIATRICS 42. Chemotherapy of Pediatric Low-Grade Gliomas 43. Chemotherapy of Pediatric High-Grade Gliomas 44. Chemotherapy for Medulloblastoma 45. Chemotherapy of Brainstem Gliomas 46. Germ Cell Tumors 47. Chemotherapy of Ependymoma - Childhood 48. Chemotherapy for CNS Atypical Teratoid/Rhabdoid Tumor 49. Chemotherapy of Central Nervous System Primitive Neuro-Ectodermal Tumors 50. Pediatric Choroid Plexus Carcinoma: Current Management and Future Directions SECTION VI. IMMUNOTHERAPY OF BRAIN TUMORS 51. The Immune Response to Glioblastoma: Overview and Focus on Checkpoint Blockade 52. Blockade of the Checkpoint Inhibitor Pathways and Activated T-cell Therapy in Brain Tumors 53. Overview of Dendritic Cell Vaccines for Brain Tumors 54. Overview of Vaccine Strategies against Epidermal Growth Factor Receptor in Brain Tumors 55. Overview of CNS Vaccines - Pediatrics SECTION VII. RESPONSE ASSESSMENT, QUALITY OF LIFE, AND NEUROPSYCHOLOGY 56. Issues in Response Assessment of Brain Tumor Chemotherapy 57. Pseudoprogression in Neuro-Oncology: Overview, Pathophysiology, and Interpretation 58. Response assessment in neuro-oncology (RANO): An update 59. Immunotherapy Response Assessment in Neuro-Oncology (iRANO) 60. Quality of Life in Neuro-Oncology 61. Neuropsychology of Chemotherapy in Brain Tumor Patients
Trade Policy 买家须知
- 关于产品：
- ● 正版保障：本网站隶属于中国国际图书贸易集团公司，确保所有图书都是100%正版。
- ● 环保纸张：进口图书大多使用的都是环保轻型张，颜色偏黄，重量比较轻。
- ● 毛边版：即书翻页的地方，故意做成了参差不齐的样子，一般为精装版，更具收藏价值。
关于退换货：- 由于预订产品的特殊性，采购订单正式发订后，买方不得无故取消全部或部分产品的订购。
- 由于进口图书的特殊性，发生以下情况的，请直接拒收货物，由快递返回：
- ● 外包装破损/发错货/少发货/图书外观破损/图书配件不全（例如：光盘等）
并请在工作日通过电话400-008-1110联系我们。
- 签收后，如发生以下情况，请在签收后的5个工作日内联系客服办理退换货：
- ● 缺页/错页/错印/脱线
关于发货时间：- 一般情况下：
- ●【现货】 下单后48小时内由北京（库房）发出快递。
- ●【预订】【预售】下单后国外发货，到货时间预计5-8周左右，店铺默认中通快递，如需顺丰快递邮费到付。
- ● 需要开具发票的客户，发货时间可能在上述基础上再延后1-2个工作日（紧急发票需求，请联系010-68433105/3213）；
- ● 如遇其他特殊原因，对发货时间有影响的，我们会第一时间在网站公告，敬请留意。
关于到货时间：- 由于进口图书入境入库后，都是委托第三方快递发货，所以我们只能保证在规定时间内发出，但无法为您保证确切的到货时间。
- ● 主要城市一般2-4天
- ● 偏远地区一般4-7天
关于接听咨询电话的时间：- 010-68433105/3213正常接听咨询电话的时间为：周一至周五上午8：30～下午5：00，周六、日及法定节假日休息，将无法接听来电，敬请谅解。
- 其它时间您也可以通过邮件联系我们：customer@readgo.cn,工作日会优先处理。
关于快递：- ● 已付款订单：主要由中通、宅急送负责派送，订单进度查询请拨打010-68433105/3213。
本书暂无推荐
本书暂无推荐
